IBDEI1Z1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31481,0)
 ;;=O36.8123^^126^1626^22
 ;;^UTILITY(U,$J,358.3,31481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31481,1,3,0)
 ;;=3^Decreased fetal movements, second trimester, fetus 3
 ;;^UTILITY(U,$J,358.3,31481,1,4,0)
 ;;=4^O36.8123
 ;;^UTILITY(U,$J,358.3,31481,2)
 ;;=^5017092
 ;;^UTILITY(U,$J,358.3,31482,0)
 ;;=O36.8133^^126^1626^28
 ;;^UTILITY(U,$J,358.3,31482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31482,1,3,0)
 ;;=3^Decreased fetal movements, third trimester, fetus 3
 ;;^UTILITY(U,$J,358.3,31482,1,4,0)
 ;;=4^O36.8133
 ;;^UTILITY(U,$J,358.3,31482,2)
 ;;=^5017099
 ;;^UTILITY(U,$J,358.3,31483,0)
 ;;=O36.8124^^126^1626^23
 ;;^UTILITY(U,$J,358.3,31483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31483,1,3,0)
 ;;=3^Decreased fetal movements, second trimester, fetus 4
 ;;^UTILITY(U,$J,358.3,31483,1,4,0)
 ;;=4^O36.8124
 ;;^UTILITY(U,$J,358.3,31483,2)
 ;;=^5017093
 ;;^UTILITY(U,$J,358.3,31484,0)
 ;;=O36.8134^^126^1626^29
 ;;^UTILITY(U,$J,358.3,31484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31484,1,3,0)
 ;;=3^Decreased fetal movements, third trimester, fetus 4
 ;;^UTILITY(U,$J,358.3,31484,1,4,0)
 ;;=4^O36.8134
 ;;^UTILITY(U,$J,358.3,31484,2)
 ;;=^5017100
 ;;^UTILITY(U,$J,358.3,31485,0)
 ;;=O36.8125^^126^1626^24
 ;;^UTILITY(U,$J,358.3,31485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31485,1,3,0)
 ;;=3^Decreased fetal movements, second trimester, fetus 5
 ;;^UTILITY(U,$J,358.3,31485,1,4,0)
 ;;=4^O36.8125
 ;;^UTILITY(U,$J,358.3,31485,2)
 ;;=^5017094
 ;;^UTILITY(U,$J,358.3,31486,0)
 ;;=O36.8135^^126^1626^30
 ;;^UTILITY(U,$J,358.3,31486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31486,1,3,0)
 ;;=3^Decreased fetal movements, third trimester, fetus 5
 ;;^UTILITY(U,$J,358.3,31486,1,4,0)
 ;;=4^O36.8135
 ;;^UTILITY(U,$J,358.3,31486,2)
 ;;=^5017101
 ;;^UTILITY(U,$J,358.3,31487,0)
 ;;=O43.011^^126^1626^32
 ;;^UTILITY(U,$J,358.3,31487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31487,1,3,0)
 ;;=3^Fetomaternal placental transfusion syndrome, first trimester
 ;;^UTILITY(U,$J,358.3,31487,1,4,0)
 ;;=4^O43.011
 ;;^UTILITY(U,$J,358.3,31487,2)
 ;;=^5017389
 ;;^UTILITY(U,$J,358.3,31488,0)
 ;;=O43.012^^126^1626^31
 ;;^UTILITY(U,$J,358.3,31488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31488,1,3,0)
 ;;=3^Fetomaternal placental transfuse syndrome, second trimester
 ;;^UTILITY(U,$J,358.3,31488,1,4,0)
 ;;=4^O43.012
 ;;^UTILITY(U,$J,358.3,31488,2)
 ;;=^5017390
 ;;^UTILITY(U,$J,358.3,31489,0)
 ;;=O43.013^^126^1626^33
 ;;^UTILITY(U,$J,358.3,31489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31489,1,3,0)
 ;;=3^Fetomaternal placental transfusion syndrome, third trimester
 ;;^UTILITY(U,$J,358.3,31489,1,4,0)
 ;;=4^O43.013
 ;;^UTILITY(U,$J,358.3,31489,2)
 ;;=^5017391
 ;;^UTILITY(U,$J,358.3,31490,0)
 ;;=O36.0110^^126^1626^55
 ;;^UTILITY(U,$J,358.3,31490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31490,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,1st tri,unsp fts
 ;;^UTILITY(U,$J,358.3,31490,1,4,0)
 ;;=4^O36.0110
 ;;^UTILITY(U,$J,358.3,31490,2)
 ;;=^5016842
 ;;^UTILITY(U,$J,358.3,31491,0)
 ;;=O36.0111^^126^1626^56
 ;;^UTILITY(U,$J,358.3,31491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31491,1,3,0)
 ;;=3^Maternal care for Anti-D antibodies,1st tri,fts 1
 ;;^UTILITY(U,$J,358.3,31491,1,4,0)
 ;;=4^O36.0111
 ;;^UTILITY(U,$J,358.3,31491,2)
 ;;=^5016843
 ;;^UTILITY(U,$J,358.3,31492,0)
 ;;=O36.0112^^126^1626^57
